1-3021702-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080431.5(ACTRT2):c.16G>A(p.Ala6Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000214 in 1,613,392 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080431.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000204 AC: 51AN: 250286Hom.: 0 AF XY: 0.000229 AC XY: 31AN XY: 135398
GnomAD4 exome AF: 0.000220 AC: 322AN: 1461154Hom.: 0 Cov.: 32 AF XY: 0.000213 AC XY: 155AN XY: 726836
GnomAD4 genome AF: 0.000151 AC: 23AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.16G>A (p.A6T) alteration is located in exon 1 (coding exon 1) of the ACTRT2 gene. This alteration results from a G to A substitution at nucleotide position 16, causing the alanine (A) at amino acid position 6 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at